Shenkman Capital Management »

Travere Therapeutics shares owned by Shenkman Capital Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Shenkman Capital Management from 13F filings

Historical chart of Shenkman Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Shenkman Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.7B 2.3M 1195.01

More positions owned by Shenkman Capital Management

Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Ishares Tr Broad Usd High (USHY)
Etsy Note 0.250% 6/1 (Principal)
Parsons Corp Del Note 2.625% 3/0 (Principal)
Doordash Note 5/1 (Principal)
Super Micro Computer Note 6/1 (Principal)
Cms Energy Corp Note 3.375% 5/0 (Principal)
Spdr Series Trust St Term High Etf (SJNK)
Rivian Automotive Note 3.625%10/1 (Principal)
Varonis Sys Note 1.000% 9/1 (Principal)
Warner Bros Discovery Com Ser A (WBD)
Integer Hldgs Corp DBCV 1.875% 3/1 (Principal)
Nutanix Note 0.500%12/1 (Principal)
Blackline Note 1.000% 6/0 (Principal)
Repligen Corp Note 1.000%12/1 (Principal)

View all positions for Shenkman Capital Management

Top funds holding Travere Therapeutics

Ing Investment Management
BlackRock
Context Capital Management
Calamos Advisors
Polar Securities
Tenor Capital Management
Wellesley Investment Advisors
Lord, Abbett & Co
Lazard Asset Management
Steelhead Partners
M&G
Citadel Advisors
Ameriprise Financial
DeepCurrents Investment Group
D. E. Shaw & Co

View all funds holding Travere Therapeutics